Author

Olaposi Idowu Omotuyi

Ekiti State UniversityORCID 0000-0002-5473-745XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Approach:diffusion model· 1 Research Focus:drug response / drug discovery· 1 Approach:simulation· 1

Frequent Co-Authors

Babatunde Oluwaseun IbitoyeiD· 1 shared Babatunji Emmanuel OyinloyeiD· 1 shared Dominic Chinedu Okonkwo· 1 shared Ehisdiame Favour Okoh· 1 shared Elizabeth Oluwatoyin Afolabi· 1 shared Emmanuel Sunday OmiriniD· 1 shared Ezekiel Abiola OlugbogiiD· 1 shared Mbang Nyong Femi-Oyewo· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Babatunde Oluwaseun IbitoyeORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioinformaticsbioRxivPreprintJul 4, 2023

Molecular Dynamics Simulations on Quercetin-3-(6-Malonylglucoside) From Morus alba Shows Optimal Inhibition of Bcl-2 with Favorable Anti-Tumor Activities.

Emmanuel Sunday Omirin, Olaposi Idowu Omotuyi, Oluwaseun Grace Afokhume…·Oluwafemi Ojo Agosile

This study identifies Quercetin-3-(6-Malonylglucoside) as a potent Bcl-2 inhibitor from Morus alba through molecular docking and simulations, suggesting its potential for cancer chemotherapy.

3 citations

simulation

𝕏 PostBluesky

BioinformaticsComputers in Biology and MedicinePeer-reviewedMar 1, 2022

SARS-CoV-2 Omicron Spike Glycoprotein Receptor Binding Domain Exhibits Super-Binder Ability with ACE2 but not Convalescent Monoclonal Antibody

Olaposi Idowu Omotuyi, Olujide Oludayo Olubiyi, Oyekanmi Nash…·Suleiman Bogoro

This study investigates the interaction of the Omicron SARS-CoV-2 spike RBD with ACE2 and a neutralizing mAb, finding enhanced ACE2 binding and reduced mAb binding efficiency.

36 citations

statistical model

𝕏 PostBluesky

BioinformaticsbioRxivPreprintApr 15, 2019

Identification of Gly/NMDAR Antagonist from Chromolaena odoratas Derived Phytoconstituents using Induced Fit Docking Approach.

Temitope Israel David, Olaposi Idowu Omotuyi, Olalekan David Agboola…·Niyi Samuel Adelakun

The paper identifies potential Gly/NMDAR antagonists from Chromolaena odorata using docking and ADMET analysis.

2 citations

diffusion modelstatistical model

𝕏 PostBluesky